Launch of Deferoxamine Noridem 500 mg in the Italian market
09/09/2018 With reference to the agreement signed on 19/04/2017 with the Greek company DEMO SA and the start of sales of Deferoxamine Noridem 2 g on 30/05/2017, C.F.I. SRL has also launched Deferoxamine Noridem 500 mg in the Italian market. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron [...]